INVO Fertility, Inc. (IVF): debt financing — INVO Bioscience raises $100k in demand promissory notes from CEO, CFO, and related party

INVO Fertility, Inc.

Received $25k from CEO Steven Shum, $25k from entity controlled by CFO Andrea Goren, and $50k from JAG Multi Investments LLC.
Interest-free until Jan 31, 2023; thereafter 10% annual interest from issuance date.
Notes payable at maturity with 10% financing fee plus accrued interest; callable with 10 days notice after 30 days.

item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INVO Fertility, Inc. incurred loan of $100,000 at 10% annual interest.

Instrument: loan
Principal: $100,000
Rate: 10% annual interest
Event: incurrence

Exact text from the filing

On December 13, 2022, INVO Bioscience, Inc. (the “Company”) received $100,000 through the issuance of demand promissory notes of which (1) $25,000 was received from our chief executive officer, Steven Shum, (2) $25,000 was received from an entity controlled by our chief financial officer, Andrea Goren, and (3) $50,000 was received from JAG Multi Investments LLC (“JAG”), a related party to Mr. Goren, who is a beneficiary of JAG but does not have any control over JAG’s investment decisions with respect to the Company.

View on SEC.gov

Browse all debt financings →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-035812

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.